Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00331981
Status:
COMPLETED
Last Update Posted:
2008-04-10
First Post:
2006-05-30
Brief Title:
Amisulpride in Schizophrenic Patients
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Study of the Efficacy and Safety After Long-Term Treatment With Amisulpride in Schizophrenic Patients
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Primary purpose
To find out how effective is long term treatment with amisulpride on the positive and negative symptoms in schizophrenic patients
To find out how safe is long term treatment with amisulpride in schizophrenic patients
Secondary purpose
To find out how effective is long term treatment with amisulpride on the quality of life in schizophrenic patients
To find out how effective is long term treatment with amisulpride on the cognitive function in schizophrenic patients
To find out how effective is long term treatment with amisulpride on the positive and negative symptoms in schizophrenic patients
To find out how safe is long term treatment with amisulpride in schizophrenic patients
Secondary purpose
To find out how effective is long term treatment with amisulpride on the quality of life in schizophrenic patients
To find out how effective is long term treatment with amisulpride on the cognitive function in schizophrenic patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None